Arete Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,139
Closed -$307K 739
2024
Q4
$307K Buy
4,139
+700
+20% +$51.9K 0.02% 549
2024
Q3
$225K Sell
3,439
-150
-4% -$9.81K 0.02% 617
2024
Q2
$332K Buy
+3,589
New +$332K 0.03% 511
2024
Q1
Sell
-3,988
Closed -$304K 482
2023
Q4
$304K Buy
3,988
+108
+3% +$8.24K 0.02% 548
2023
Q3
$269K Sell
3,880
-344
-8% -$23.8K 0.05% 369
2023
Q2
$398K Sell
4,224
-3,488
-45% -$329K 0.04% 415
2023
Q1
$638K Buy
7,712
+71
+0.9% +$5.87K 0.05% 290
2022
Q4
$570M Buy
7,641
+2,173
+40% +$162M 0.05% 300
2022
Q3
$452K Sell
5,468
-4
-0.1% -$331 0.04% 319
2022
Q2
$520K Sell
5,472
-270
-5% -$25.7K 0.05% 237
2022
Q1
$676K Sell
5,742
-502
-8% -$59.1K 0.06% 233
2021
Q4
$802K Buy
6,244
+595
+11% +$76.4K 0.07% 212
2021
Q3
$640K Buy
5,649
+555
+11% +$62.9K 0.07% 215
2021
Q2
$460K Buy
5,094
+108
+2% +$9.75K 0.06% 218
2021
Q1
$417K Buy
4,986
+125
+3% +$10.5K 0.05% 266
2020
Q4
$442K Buy
4,861
+127
+3% +$11.5K 0.06% 251
2020
Q3
$373K Buy
4,734
+390
+9% +$30.7K 0.06% 259
2020
Q2
$300K Buy
4,344
+264
+6% +$18.2K 0.05% 296
2020
Q1
$257K Sell
4,080
-681
-14% -$42.9K 0.05% 266
2019
Q4
$370K Sell
4,761
-300
-6% -$23.3K 0.06% 269
2019
Q3
$371K Buy
5,061
+459
+10% +$33.6K 0.07% 259
2019
Q2
$283K Buy
4,602
+333
+8% +$20.5K 0.05% 307
2019
Q1
$272K Sell
4,269
-30
-0.7% -$1.91K 0.06% 303
2018
Q4
$219K Hold
4,299
0.05% 319
2018
Q3
$249K Buy
+4,299
New +$249K 0.06% 302